1 results match your criteria: "Shenzhen Baoan Clinical Medical College of Guangdong Medical University[Affiliation]"
Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers.
Front Pharmacol
November 2024
Department of Clinical Laboratory, People's Hospital of Bao'an District, Shenzhen Baoan Clinical Medical College of Guangdong Medical University, Shenzhen, China.
Background: CLDN18.2 is a widely researched drug target. However, previous research has primarily been based on immunohistochemistry results and focused on gastric cancer.
View Article and Find Full Text PDF